Waverley Pharma Inc (WAVE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.059x

Based on the latest financial reports, Waverley Pharma Inc (WAVE) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-138.86K ≈ $-100.45K USD) by net assets (CA$-2.36 Million ≈ $-1.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Waverley Pharma Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Waverley Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Waverley Pharma Inc (WAVE) total liabilities for a breakdown of total debt and financial obligations.

Waverley Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Waverley Pharma Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HODL SPAC EUROPE AB F:NW1	0.039x
Anexo Group Plc LSE:ANX	-0.057x
CABASSE S.A. EO -50 F:LB0	N/A
CT UK High Income Trust Plc LSE:CHIB	0.025x
Works co uk PLC LSE:WRKS	1.780x
GRIT Real Estate Income Group LSE:GR1T	0.058x
ONETECH SOLUTIONS HOLDINGS BERHAD KLSE:03041	-0.145x
Multistack International Ltd AU:MSI	-0.834x

Annual Cash Flow Conversion Efficiency for Waverley Pharma Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Waverley Pharma Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Waverley Pharma Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-2.03 Million ≈ $-1.47 Million	CA$-410.19K ≈ $-296.73K	0.202x	-77.52%
2023-12-31	CA$-1.14 Million ≈ $-822.30K	CA$-1.02 Million ≈ $-738.66K	0.898x	+513.44%
2022-12-31	CA$1.09 Million ≈ $789.27K	CA$-237.06K ≈ $-171.49K	-0.217x	+51.33%
2021-12-31	CA$1.79 Million ≈ $1.29 Million	CA$-798.78K ≈ $-577.82K	-0.446x	-152.15%
2020-12-31	CA$2.04 Million ≈ $1.48 Million	CA$-361.70K ≈ $-261.65K	-0.177x	+64.34%
2019-12-31	CA$2.85 Million ≈ $2.06 Million	CA$-1.41 Million ≈ $-1.02 Million	-0.497x	-35.82%
2018-12-31	CA$3.97 Million ≈ $2.87 Million	CA$-1.45 Million ≈ $-1.05 Million	-0.366x	-1600.85%
2017-12-31	CA$5.06 Million ≈ $3.66 Million	CA$-108.69K ≈ $-78.62K	-0.021x	-100.23%
2016-12-31	CA$-11.62K ≈ $-8.41K	CA$-108.69K ≈ $-78.62K	9.350x	-9.27%
2015-12-31	CA$-10.55K ≈ $-7.63K	CA$-108.69K ≈ $-78.62K	10.306x	--

About Waverley Pharma Inc

V:WAVE Canada Biotechnology

Market Cap

$390.63K

CA$540.00K CAD

Market Cap Rank

#30817 Global

#1657 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.04

All Time High

CA$0.60